Fgfr3–Wnt signaling crosstalk is involved in maintaining cranial suture integrity

Abstract

Cranial suture formation is a dynamic process that requires precise cellular and molecular coordination to regulate bone growth and maintain suture homeostasis. The Fibroblast Growth Factor Receptor 3 (FGFR3) signaling pathway is among the major pathways disrupted in craniosynostosis; however, its precise role during cranial suture formation is still unknown. Using a relevant fgfr3 LoF zebrafish model exhibiting abnormal suture morphology, we demonstrated for the first time that Fgfr3 plays a pleiotropic role in both the formation and maintenance of cranial sutures. Transmission electron microscopy and second harmonic generation imaging revealed that Fgfr3 is essential for the proper organization of the collagen network within the suture. Using specific transgenic reporter lines, we showed that Fgfr3 is crucial for regulating osteogenesis in this region. Specifically, Fgfr3 limits the number of osteoprogenitors at the osteogenic front and promotes osteoblast maturation at the suture edge. RNAscope analyses further revealed that loss of Fgfr3 led to significant upregulation of fgf18 expression. Finally, our findings show that loss of Fgfr3 results in the activation of the canonical Wnt pathway, and possibly the BMP pathway, within cranial sutures. Pharmacological inhibition of canonical Wnt signaling during suture development using the β-catenin inhibitor XAV939 restored fgf18 expression, partially normalized levels of the BMP antagonist grem1, reduced SMAD1/5 phosphorylation, and produced a significant improvement in cranial suture morphology. In conclusion, these findings position Fgfr3 as a central regulator of cranial suture formation and homeostasis, acting through intricate cross-talk between the FGF, canonical Wnt, and possibly BMP signaling pathways. These data offer new insights into the biology of cranial suture and FGFR3-related craniosynostoses.

References

[1] Twigg SRF, Wilkie AOM. A genetic-pathophysiological framework for craniosynostosis. Am. J. Hum. Genet., 2015, 97: 359-377

[2] Cornille M, Dambroise E, Komla-Ebri D, Kaci N, Biosse-Duplan M, Di Rocco F, et al.. Animal models of craniosynostosis. Neurochirurgie, 2019, 65: 202-209

[3] Lana-Elola E, Rice R, Grigoriadis AE, Rice DPC. Cell fate specification during calvarial bone and suture development. Dev. Biol., 2007, 311: 335-346

[4] Holmes G, Gonzalez-Reiche AS, Lu N, Zhou X, Rivera J, Kriti D, et al.. Integrated transcriptome and network analysis reveals spatiotemporal dynamics of calvarial suturogenesis. Cell Rep., 2020, 32: 107871

[5] Farmer DT, Dukov JE, Chen HJ, Arata C, Hernandez-Trejo J, Xu P, et al.. Cellular transitions during cranial suture establishment in zebrafish. Nat. Commun., 2024, 15 ArticleID: 6948

[6] Maruyama T, Jeong J, Sheu T-J, Hsu W. Stem cells of the suture mesenchyme in craniofacial bone development, repair and regeneration. Nat. Commun., 2016, 7 ArticleID: 10526

[7] Zhao H, Feng J, Ho TV, Grimes W, Urata M, Chai Y. The suture provides a niche for mesenchymal stem cells of craniofacial bones. Nat. Cell Biol., 2015, 17: 386-396

[8] Maruyama T, Stevens R, Boka A, DiRienzo L, Chang C, Yu HI, et al.. BMPR1A maintains skeletal stem cell properties in craniofacial development and craniosynostosis. Sci. Transl. Med., 2021, 13 ArticleID: eabb4416

[9] Wilk K, Yeh SA, Mortensen LJ, Ghaffarigarakani S, Lombardo CM, Bassir SH, et al.. Postnatal calvarial skeletal stem cells expressing PRX1 reside exclusively in the calvarial sutures and are required for bone regeneration. Stem Cell Rep., 2017, 8: 933-946

[10] Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, et al.. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018, 562: 133-139

[11] Teng CS, Ting MC, Farmer DT, Brockop M, Maxson RE, Crump JG. Altered bone growth dynamics prefigure craniosynostosis in a zebrafish model of Saethre-Chotzen syndrome. Elife, 2018, 7 ArticleID: e37024

[12] Bok S, Yallowitz AR, Sun J, McCormick J, Cung M, Hu L, et al.. A multi-stem cell basis for craniosynostosis and calvarial mineralization. Nature, 2023, 621: 804-812

[13] Herring SW. Mechanical influences on suture development and patency. Front. Oral. Biol., 2008, 12: 41-56

[14] Izu Y, Ezura Y, Koch M, Birk DE, Noda M. Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis. Cell Tissue Res., 2016, 364: 623-635

[15] Izu Y, Sun M, Zwolanek D, Veit G, Williams V, Cha B, et al.. Type XII collagen regulates osteoblast polarity and communication during bone formation. J. Cell Biol., 2011, 193: 1115-1130

[16] Huang X, Li Z, Liu P, Wu M, Liu AQ, Hu C, et al.. Gli1+ cells residing in bone sutures respond to mechanical force via IP3R to mediate osteogenesis. Stem Cells Int., 2021, 2021: 8138374

[17] Jing D, Chen Z, Men Y, Yi Y, Wang Y, Wang J, et al.. Response of Gli1+ suture stem cells to mechanical force upon suture expansion. J. Bone Min. Res., 2022, 37: 1307-1320

[18] Daponte V, Tonelli F, Masiero C, Syx D, Exbrayat-Héritier C, Biggiogera M, et al.. Cell differentiation and matrix organization are differentially affected during bone formation in osteogenesis imperfecta zebrafish models with different genetic defects impacting collagen type I structure. Matrix Biol., 2023, 121: 105-126

[19] Ga, M., Sj, O., Ir, M., Ka, P. & Ew, J. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet.11, 462–464 (1995).

[20] Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, et al.. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet., 1997, 60: 555-564

[21] Makrythanasis P, Temtamy S, Aglan MS, Otaify GA, Hamamy H, Antonarakis SE. A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly. Hum. Mutat., 2014, 35: 959-963

[22] Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 1996, 84: 911-921

[23] Nah H-D, Koyama E, Agochukwu NB, Bartlett SP, Muenke M. Phenotype profile of a genetic mouse model for Muenke syndrome. Childs Nerv. Syst., 2012, 28: 1483-1493

[24] Cornille M, Moriceau S, Khonsari RH, Heuzé Y, Loisay L, Boitez V, et al.. FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model. J. Exp. Med., 2022, 219e20201879

[25] Laue K, Pogoda HM, Daniel PB, van Haeringen A, Alanay Y, von Ameln S, et al.. Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. Am. J. Hum. Genet., 2011, 89: 595-606

[26] Pereur R, Dambroise E. Insights into craniofacial development and anomalies: exploring Fgf signaling in zebrafish models. Curr. Osteoporos. Rep., 2024, 22: 340-352

[27] Sun X, Zhang R, Chen H, Du X, Chen S, Huang J, et al.. Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling. Theranostics, 2020, 10: 7111-7130

[28] Dambroise E, Ktorza I, Brombin A, Abdessalem G, Edouard J, Luka M, et al.. Fgfr3 Is a positive regulator of osteoblast expansion and differentiation during zebrafish skull vault development. J. Bone Min. Res., 2020, 35: 1782-1797

[29] Izu Y, Birk DE. Collagen XII mediated cellular and extracellular mechanisms in development, regeneration, and disease. Front. Cell Dev. Biol., 2023, 11: 1129000

[30] Miao KZ, Cozzone A, Caetano-Lopes J, Harris MP, Fisher S. Osteoclast activity sculpts craniofacial form to permit sensorineural patterning in the zebrafish skull. Front. Endocrinol., 2022, 13: 969481

[31] Farmer DT, Mlcochova H, Zhou Y, Koelling N, Wang G, Ashley N, et al.. The developing mouse coronal suture at single-cell resolution. Nat. Commun., 2021, 12 ArticleID: 4797

[32] Moshkovsky AR, Kirschner MW. The nonredundant nature of the Axin2 regulatory network in the canonical Wnt signaling pathway. Proc. Natl. Acad. Sci. USA., 2022, 119 ArticleID: e2108408119

[33] Di Rocco F, Biosse Duplan M, Heuzé Y, Kaci N, Komla-Ebri D, Munnich A, et al.. FGFR3 mutation causes abnormal membranous ossification in achondroplasia. Hum. Mol. Genet., 2014, 23: 2914-2925

[34] Kague E, Roy P, Asselin G, Hu G, Simonet J, Stanley A, et al.. Osterix/Sp7 limits cranial bone initiation sites and is required for formation of sutures. Dev. Biol., 2016, 413: 160-172

[35] Bobzin L, Nickle A, Ko S, Ince M, Huang A, Bhojwani A, et al.. FGFR2 directs inhibition of WNT signaling to regulate anterior fontanelle closure during skull development. Development, 2025, 152 ArticleID: dev204264

[36] Menon S, Salhotra A, Shailendra S, Tevlin R, Ransom RC, Januszyk M, et al.. Skeletal stem and progenitor cells maintain cranial suture patency and prevent craniosynostosis. Nat. Commun., 2021, 12 ArticleID: 4640

[37] Mirando AJ, Maruyama T, Fu J, Yu H-MI, Hsu W. β-catenin/cyclin D1 mediated development of suture mesenchyme in calvarial morphogenesis. BMC Dev. Biol., 2010, 10: 116

[38] Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, et al.. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev., 2002, 16: 870-879

[39] Reinhold MI, Naski MC. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J. Biol. Chem., 2007, 282: 3653-3663

[40] Jiang T, Ge S, Shim YH, Zhang C, Cao D. Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells. Int J. Clin. Exp. Pathol., 2015, 8: 2946-2954

[41] Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT. The BMP antagonist noggin regulates cranial suture fusion. Nature, 2003, 422: 625-629

[42] Matsushita T, Wilcox WR, Chan YY, Kawanami A, Bükülmez H, Balmes G, et al.. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Hum. Mol. Genet., 2009, 18: 227-240

[43] Ng JQ, Jafarov TH, Little CB, Wang T, Ali AM, Ma Y, et al.. Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis. Nat. Commun., 2023, 14 ArticleID: 6909

[44] Izu Y, Adams SM, Connizzo BK, Beason DP, Soslowsky LJ, Koch M, et al.. Collagen XII mediated cellular and extracellular mechanisms regulate establishment of tendon structure and function. Matrix Biol., 2021, 95: 52-67

[45] Gregory CA, Ma J, Lomeli S. The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction. Front. Mol. Biosci., 2024, 11: 1376091

[46] Knopf F, Hammond C, Chekuru A, Kurth T, Hans S, Weber CW, et al.. Bone regenerates via dedifferentiation of osteoblasts in the zebrafish fin. Dev. Cell, 2011, 20: 713-724

[47] Moro E, Ozhan-Kizil G, Mongera A, Beis D, Wierzbicki C, Young RM, et al.. In vivo Wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains. Dev. Biol., 2012, 366: 327-340

[48] Tonelotto V, Consorti C, Facchinello N, Trapani V, Sabatelli P, Giraudo C, et al.. Collagen VI ablation in zebrafish causes neuromuscular defects during developmental and adult stages. Matrix Biol., 2022, 112: 39-61

[49] Bader HL, Keene DR, Charvet B, Veit G, Driever W, Koch M, et al.. Zebrafish collagen XII is present in embryonic connective tissue sheaths (fascia) and basement membranes. Matrix Biol., 2009, 28: 32-43

[50] Raoux C, Schmeltz M, Bied M, Alnawaiseh M, Hansen U, Latour G, et al.. Quantitative structural imaging of keratoconic corneas using polarization-resolved SHG microscopy. Biomed. Opt. Express, 2021, 12: 4163-4178

Funding

Agence Nationale de la Recherche (French National Research Agency)(ANR-21-CE14-0010)

Institut Imagine

RIGHTS & PERMISSIONS

The Author(s)